World Library  
Flag as Inappropriate
Email this Article

4-Fluoromethylphenidate

Article Id: WHEBN0047956615
Reproduction Date:

Title: 4-Fluoromethylphenidate  
Author: World Heritage Encyclopedia
Language: English
Subject: HDMP-28, Carboxylate esters, Piperidines, Stimulants, Designer drugs
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

4-Fluoromethylphenidate

4-Fluoromethylphenidate
Systematic (IUPAC) name
methyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate
Identifiers
CAS Registry Number
PubChem CID:
ChemSpider  Y
Chemical data
Formula C14H18FNO2
Molecular mass 251.3 g/mol

4-Fluoromethylphenidate (also known as 4-FMPH and 4F-MPH) is a stimulant drug that acts as a higher efficiency dopamine reuptake inhibitor than the closely related methylphenidate.[1][2][3][4][5]

Legal Status

4-Fluromethylphenidate is a Schedule I controlled substance in the US state Alabama.[6]

See also

References

  1. ^ Howard M. Deutsch, Qing Shi, Ewa Gruszecka-Kowalik, Margaret M. Schweri (March 1996). "Synthesis and Pharmacology of Potential Cocaine Antagonists. 2. Structure−Activity Relationship Studies of Aromatic Ring-Substituted Methylphenidate Analogs". Journal of Medicinal Chemistry 39 (6): 1201–1209.  
  2. ^ M. M. Schweri, H. M. Deutsch, A.T. Massey, S. G. Holtzman (May 2002). "Biochemical and Behavioral Characterization of Novel Methylphenidate Analogs". The Journal of Pharmacology and Experimental Therapeutics 301 (2): 527–535.  
  3. ^ Huw M.L. Davies, Darrin W. Hopper, Tore Hansen, Quixu Liu, Steven R. Childers (April 2004). "Synthesis of methylphenidate analogues and their binding affinities at dopamine and serotonin transport sites". Bioorganic & Medicinal Chemistry Letters 14 (7): 1799–1802.  
  4. ^ Milind Misra, Qing Shi, Xiaocong Ye, Ewa Gruszecka-Kowalik, Wei Bu, Zhanzhu Liu, Margaret M. Schweri, Howard M. Deutsch, Carol A. Venanzi (October 2010). "Quantitative structure–activity relationship studies of threo-methylphenidate analogs". Bioorganic & Medicinal Chemistry 18 (20): 7221–7238.  
  5. ^ Satendra Singh (February 2000). "Chemistry, Design, and Structure−Activity Relationship of Cocaine Antagonists". Chemical Reviews 100 (3): 925–1024.  
  6. ^ "Alabama Senate Bill 333 - Controlled substances, Schedule I, additional synthetic controlled substances and analogue substances included in, trafficking in controlled substance analogues, requisite weight increased, Secs. 13A-12-231, 20-2-23 am'd.". March 2014. Retrieved 28 September 2015. 
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 



Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.